Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of the antibacterial activity of rifampicin and other antibiotics.

× No keyword cloud information.

24 in total

1. Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infection.

Authors: David M Rothstein; Ronald S Farquhar; Klari Sirokman; Karen L Sondergaard; Charles Hazlett; Angelia A Doye; Judith K Gwathmey; Steve Mullin; John van Duzer; Christopher K Murphy
Journal: Antimicrob Agents Chemother Date: 2006-08-28 Impact factor: 5.191

2. Effect of rifampin on nasal carriage of Staphylococcus aureus.

Authors: M A Sande; G L Mandell
Journal: Antimicrob Agents Chemother Date: 1975-03 Impact factor: 5.191

3. In vitro interaction between rifampin and clindamycin against pathogenic coagulase-negative staphylococci.

Authors: M Arditi; R Yogev
Journal: Antimicrob Agents Chemother Date: 1989-02 Impact factor: 5.191

4. Intracellular bactericidal effects of rifampicin in both normal and chronic ganulomatous disease polymorphs.

Authors: G Ezer; J F Soothill
Journal: Arch Dis Child Date: 1974-06 Impact factor: 3.791

5. Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics.

Authors: L D Sabath; C Garner; C Wilcox; M Finland
Journal: Antimicrob Agents Chemother Date: 1976-06 Impact factor: 5.191

6. Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus.

Authors: C M Brandt; M S Rouse; B M Tallan; W R Wilson; J M Steckelberg
Journal: Antimicrob Agents Chemother Date: 1994-09 Impact factor: 5.191

Comparison of the antibacterial activity of rifampicin and other antibiotics.

1. Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infection.

2. Effect of rifampin on nasal carriage of Staphylococcus aureus.

3. In vitro interaction between rifampin and clindamycin against pathogenic coagulase-negative staphylococci.

4. Intracellular bactericidal effects of rifampicin in both normal and chronic ganulomatous disease polymorphs.

5. Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics.

6. Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus.

7. Bacteraemia due to a rifampicin-resistant strain of Bacteroides fragilis.

8. Trimethoprim-rifampin, a new combination agent: efficacy in localized urinary infection and influence on microflora.

9. Rifampin-blood-agar as a selective medium for the isolation of certain anaerobic bacteria.

10. In vitro development of rifampin resistance in clinical isolates of Haemophilus influenzae type b.